Jain Global »

Theravance Biopharma shares owned by Jain Global

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Jain Global

Quarter filed Position value Share count Share price at filing
2025-09-30 $295k 20k 14.60

More positions owned by Jain Global

Spdr Gold Tr Gold Shs Call Option (GLD)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Tesla Motors Put Option (TSLA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr China Lg-cap Etf Put Option (FXI)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Financial Put Option (XLF)
Vaneck Etf Trust Gold Miners Etf Put Option (GDX)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Ishares Tr Iboxx Inv Cp Etf Put Option (LQD)
Select Sector Spdr Tr Energy Put Option (XLE)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)

View all positions for Jain Global

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Oasis Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Morgan Stanley

View all funds holding Theravance Biopharma